- May 22, 2017
- Posted by:
- Category: FundingSMEs.com
Akonni Biosystems has raised $4 million in Series D funding.
Founded in 2003, Akonni Biosystems is preparing its first FDA submission for a clinical IVD pharmacogenomic test on the TruDx®2000 platform, utilizing its proprietary TruArray® 3D gel-drop microarray technology. In addition, the company plans to list its automated sample prep instrument with the FDA as a Class-I device. It is also accelerating development of its TruDx®3000.
The company will use the new money to continue to develop its platform.
|Founder / CEO||Charles Daitch|
|Investors||M.M. Dillon & Co.|
|Previous Investors||Argonne National Laboratory|
|Maryland Venture Fund|
|National Institutes of Health|